Treatment of Clostridium difficile-associated disease with teicoplanin.

AUTOR(ES)

de Lalla, F

RESUMO

Forty-seven patients affected by Clostridium difficile-associated disease were treated orally with either vancomycin (patients hospitalized from February 1984 to February 1987) or teicoplanin (from March 1987 to December 1988). All patients given teicoplanin remained asymptomatic after discontinuation of treatment, and all but one were also cleared of C. difficile. In the vancomycin group, clinical symptoms recurred in 3 of 23 evaluable patients, and follow-up cultures were positive in another asymptomatic case.

Documentos Relacionados

• Clostridium difficile-associated diarrhea in adults
• Clinical risk factors for Clostridium difficile-associated diseases
• Epidemiology of Recurrences or Reinfections of Clostridium difficile-Associated Diarrhea
• Prospective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrhea.
• Commercial latex agglutination test for detection of Clostridium difficile-associated diarrhea.